» Articles » PMID: 21130246

Major Depression Drives Severity of American Urological Association Symptom Index

Overview
Journal Urology
Specialty Urology
Date 2010 Dec 7
PMID 21130246
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate the unclear relationship between depression and benign prostatic hyperplasia (BPH) by assessing depression's effect on the American Urological Association Symptom Index (AUA-SI) scores. Depression is a common illness associated with chronic inflammatory disease states. Data have suggested a significant role of inflammation in the progression of BPH.

Methods: The present prospective study involved 547 male patients who completed the Geriatric Depression Scale and the AUA-SI. We evaluated whether the mean AUA-SI score and the severity categories differed by the state of depression. We then conducted binary logistic regression analysis with forward stepwise regression to assess the relationship between depression and the severity symptoms as determined by the AUA-SI score.

Results: Of the cohort, 22% screened positive for depressive symptoms. The depressed patients (Geriatric Depression Scale score >5) reported significantly more severe symptoms (mean AUA-SI score 16.61 ± 9.89) compared with the nondepressed patients (Geriatric Depression Scale score of ≤5 and mean AUA-SI score 10.65 ± 7.29; F = 40.19, P <.001). After controlling for socioeconomic and demographic variables, depressed patients were 3 times more likely to present with severe symptoms (odds ratio 3.079, 95% confidence interval 1.129-8.402, P = .028).

Conclusions: A significant association was found between depression and BPH. However, it remains unclear whether this relationship represents unidirectional or bidirectional causality. Additional research is imperative to assess the nature of this correlation, either to address comorbid depression in patients with BPH or to ensure that depressed patients do not report falsely elevated symptoms.

Citing Articles

Global burden of benign prostatic hyperplasia in males aged 60-90 years from 1990 to 2019: results from the global burden of disease study 2019.

Ye Z, Wang J, Xiao Y, Luo J, Xu L, Chen Z BMC Urol. 2024; 24(1):193.

PMID: 39237966 PMC: 11376082. DOI: 10.1186/s12894-024-01582-w.


Longitudinal association between the dynamic nature of depression with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).

Xie Z, Liu X, Hu Z, Dong C BMC Public Health. 2024; 24(1):1121.

PMID: 38654263 PMC: 11040863. DOI: 10.1186/s12889-024-18618-3.


The relationship between depression and benign prostatic hyperplasia in middle-aged and elderly men in India: a large-scale population study.

Liu X, Ma K, Yang L, Peng Z, Song P, Liu Z BMC Public Health. 2023; 23(1):2152.

PMID: 37924045 PMC: 10625190. DOI: 10.1186/s12889-023-17027-2.


Marijuana, Alcohol, and ED: Correlations with LUTS/BPH.

Lloyd G, Wiesen B, Atwell M, Malykhina A Curr Urol Rep. 2021; 22(4):21.

PMID: 33554319 PMC: 8054558. DOI: 10.1007/s11934-020-01031-9.


A possible mechanism underlying mood disorders associated with LUTS: Chronic bladder outlet obstruction causes NLRP3-dependent inflammation in the hippocampus and depressive behavior in rats.

Hughes Jr F, Hirshman N, Malick H, White S, Jin H, Harper S Neurourol Urodyn. 2020; 39(6):1700-1707.

PMID: 32602164 PMC: 8793365. DOI: 10.1002/nau.24448.